Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complexity-enhancing Drugs to Treat Disorders of Consciousness (DoC): a Ketamine Study

NCT05343507 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT05343507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complexity-enhancing Drugs to Treat Disorders of Consciousness (DoC): a Ketamine Study
Lead sponsor
University of Liege
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 1, 2022
Completion date
May 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of consciousness